General Office of the General Administration of the people's Republic of China solicits opinions on technical guidelines for the naming of generic names of Chinese patent medicines (Draft for comments)
-
Last Update: 2017-01-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: CFDA 2017-1-12 in order to further standardize the naming of Chinese patent medicines, the State Food and Drug Administration drafted the technical guidelines for naming generic names of Chinese patent medicines (Draft for comments), which is now open to the public for comments Please send relevant comments to the State Food and Drug Administration (drug and cosmetic registration administration department) by email before February 15, 2017 Contact: Wu Dianzhen email: wudz@cfda.gov.cn Annex: technical guidelines for generic name naming of Chinese patent medicine (Draft for comments) General Office of food and Drug Administration January 9, 2017 Annex: technical guidelines for generic name naming of Chinese patent medicine (Draft for comments) Docx
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
